Dr. Andrea Katz, M.D.
What this data tells you about Dr. Katz
Dr. Andrea Katz is a medical oncology in New Smyrna Beach, FL, with 18 years in practice. Based on federal Medicare data, Dr. Katz performed 47,470 Medicare services across 1,975 unique beneficiaries.
Between the years covered by Open Payments, Dr. Katz received a total of $3,126 from 46 pharmaceutical and/or device companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Katz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 32,640 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 5,040 | $18 | $45 |
| Epoetin alfa injection (Retacrit) for anemia | 2,660 | $6 | $34 |
| Contrast dye for imaging (iodine-based) | 1,900 | $0 | $1 |
| Dexamethasone injection (steroid) | 824 | $0 | $1 |
| Blood draw (venipuncture) | 729 | $8 | $13 |
| Complete blood count (CBC) with differential | 724 | $7 | $33 |
| Office visit, established patient (30-39 min) | 605 | $94 | $335 |
| Comprehensive metabolic blood panel | 519 | $10 | $46 |
| Bilirubin level, direct | 280 | $5 | $22 |
| Drug injection, under skin or into muscle | 214 | $11 | $73 |
| Carcinoembryonic antigen (cea) protein level | 135 | $19 | $83 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 130 | $23 | $104 |
| Administration of chemotherapy into vein, 1 hour or less | 112 | $104 | $465 |
| Office visit, established patient, complex (40-54 min) | 106 | $139 | $450 |
| Magnesium level test | 102 | $6 | $29 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 84 | $50 | $212 |
| Administration of chemotherapy into vein, each additional hour | 60 | $23 | $98 |
| Administration of additional new drug or substance into vein, 1 hour or less | 58 | $53 | $231 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 56 | $1 | $6 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 54 | $55 | $237 |
| Injection of additional new drug or substance into vein | 52 | $12 | $68 |
| Thyroid stimulating hormone (TSH) test | 49 | $16 | $73 |
| Free thyroxine (T4) test | 45 | $9 | $39 |
| Lactate dehydrogenase (enzyme) level | 42 | $6 | $26 |
| New patient office visit, complex (60-74 min) | 39 | $175 | $633 |
| Hospital follow-up visit, high complexity | 38 | $96 | $286 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 36 | $20 | $89 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 34 | $1,089 | $3,661 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 34 | $375 | $982 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 19 | $4 | $15 |
| Initial hospital admission, high complexity | 19 | $141 | $574 |
| Ct scan of chest with contrast | 18 | $46 | $841 |
| CT scan of abdomen and pelvis with contrast | 13 | $164 | $879 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
13.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Katz is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Katz experienced with iron infusion (feraheme)?
Does Dr. Katz receive payments from pharmaceutical companies?
How do Dr. Katz's costs compare to other medical oncologys in New Smyrna Beach?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology